Medisur (Mar 2022)

Diagnostic utility of rapid tests to detect IgG/IgM antibodies against COVID-19

  • Pedro Sánchez Frenes,
  • Dayamí García Torres,
  • María de Jesús Sánchez Bouza,
  • Gippsy Mendoza Cartaya,
  • Mavis Portela Sánchez

Journal volume & issue
Vol. 20, no. 2
pp. 374 – 381

Abstract

Read online

Background: Rapid tests for the diagnosis of SARS-CoV-2 are attractive options due to their simplicity, speed and cost-effectiveness; but they have different degrees of sensitivity and diagnostic specificity.Objective: to evaluate the analytical performance of rapid tests to detect IgG/IgM antibodies against COVID-19.Methods: descriptive study, carried out with patients admitted to the Héroes de Playa Girón Specialized Ambulatory Center, in Cienfuegos, with a presumptive, probable or confirmed diagnosis of COVID-19 during two periods of time. All of them underwent a rapid test to detect anti-COVID-19 antibodies, in addition to a confirmatory molecular biology test. Diagnostic sensitivity and specificity, predictive values, and rapid test efficiency were calculated within a 95% confidence interval.Results: excellent specificity (98.75%) and regular sensitivity (54.54%) were obtained, as well as good predictive values and overall diagnostic efficiency.Conclusion: The rapid anti-COVID-19 tests evaluated showed adequate diagnostic performance. They constitute an affordable and valuable diagnostic alternative to assess previous exposure to SARS-CoV-2. Its clinical use is restricted to certain medical situations; however, they constitute a useful epidemiological tool.

Keywords